Article

Global Liver Institute Applauds Trump Administration for Executive Order to Improve America

Key measures include calling for increased transparency and accountability in the performance of the nation’s 58 Organ Procurement Organizations (OPOs) and increasing and expanding the reimbursement for living donors.

Responsiveness to Patient Advocates Truly Puts Patients First

Today the President signed an executive order and announced a series of initiatives under the title Advancing American Kidney Health; however, several provisions will benefit the 13,192 liver patients waiting for transplant. Seventeen hundred liver patients die waiting each year.

Key measures include calling for increased transparency and accountability in the performance of the nation’s 58 Organ Procurement Organizations (OPOs) and increasing and expanding the reimbursement for living donors.

GLI has been at the forefront of the effort to establish objective, meaningful, and independently verifiable metrics and performance standards for the organizations that are responsible for managing the donation of organs for transplant. The US is currently ranked #5 in the world with a more than 50% lower donation rate than countries such as Spain.

Read the full release.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
David Awad, PharmD, BCOP
Andrew Kuykendall, MD, Moffitt Cancer Center
Merrill H. Stewart, MD
Dr Margrit Wiesendanger
David Awad, PharmD, BCOP
H. John Beardsley, MBA, and Fauzea Hussain, MPH, sitting for a video interview
Dr Margrit Wiesendanger
Ibrahim Aldoss, MD, associate professor, City of Hope
Manmeet Ahluwalia, MD, MBA, FASCO, chief of medical oncology, chief scientific officer, and deputy director of the Miami Cancer Institute of Baptist Health South Florida
Cathy Eng, MD, FACP, FASCO
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo